FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Case sensitive SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym Active Case sensitive SNOMED CT model component

131244 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set Is a Historical association true Inferred relationship Some
Members associationTargetComponent
(Anti-D (rhesus) globulin) or (administration of) Administration of human anti-D immunoglobulin
(Anti-D (rhesus) globulin) or (therapy) Administration of human anti-D immunoglobulin
(Anti-D (rhesus) globulin) or (therapy) Administration of human anti-D immunoglobulin
(Carcinoma in situ cervix uteri) or (cerv intraepith neoplasia) or (cervix Ca in situ) Carcinoma in situ of uterine cervix
(GIT disorders NOS) or (kraurosis of anus) or (proctitis) or (rectal irritation) or (stercoral ulcer) Lichen sclerosus of anus
(Labour problem factors) or (problems affecting labour NOS) Disorder of labour / delivery
(Labour problem factors) or (problems affecting labour NOS) Disorder of labour / delivery
(Lactation problems) or (breast/lactation problems NOS) Disorder of lactation
(Lymphatic tissue carcinoma) or (lymphoma) Malignant lymphoma
(Mechanical complication of cardiac device) or (device problems) or (problems with prostheses) Mechanical complication of cardiovascular device
(Mechanical complication of cardiac device) or (device problems) or (problems with prostheses) Mechanical complication of cardiovascular device
(Mechanical complication of cardiac device, implant and graft) or (leakage due to cardiac device) Mechanical complication of cardiovascular device
(Monster) or (monster NOS) Congenital anomaly
(Monster) or (monster NOS) Congenital anomaly
(Post-operative problem NOS) or (postcardiotomy syndrome) Post-pericardiotomy syndrome
(Post-operative problem NOS) or (postcardiotomy syndrome) Post-pericardiotomy syndrome
(Recurrent aphthous ulceration) or (recurrent mouth ulcers) Recurrent ulcer of mouth
(Sprains and strains NOS) or (sprain: [joint NOS] or [ligament NOS] or [muscle NOS] or [rectus sprain] or [tendon NOS]) or (tendon rupture NOS) Strain of rectus abdominus muscle
11-Deoxy, 17-hydroxycorticosterone 11-deoxycortisol
11-Oxy fraction of 17-KS 11-oxy-17-ketosteroid
11-Oxycorticosterone 11-oxycorticosteroid
12p partial monosomy syndrome Deletion of part of short arm of chromosome 12
15q partial monosomy syndrome Partial deletion of long arm of chromosome 15
15q partial trisomy syndrome Partial duplication of long arm of chromosome 15
16p partial trisomy syndrome Duplication of part of short arm of chromosome 16
16q partial monosomy syndrome Partial deletion of long arm of chromosome 16
16q partial trisomy syndrome Duplication of part of long arm of chromosome 16
17-Hydroxycorticosteroid 17-hydroxycorticosteroid
18-Hydroxycorticosterone dehydrogenase deficiency Corticosterone 18-monooxygenase deficiency
2,3-Diaminopropionate oxalyltransferase 2,3-diaminopropionate N-oxalyltransferase
2,3,5-Trichlorophenoxyacetic acid 2,4,5-trichlorophenoxyacetic acid
2,5-Diokovalerate dehydrogenase 2,5-dioxovalerate dehydrogenase
2-Butanone Methyl ethyl ketone
2-Nitro-1,1-bis(p-chlorophenyl) butane 1,1-bis(4-chlorophenyl)-2-nitrobutane
3% Acetic acid Acetic acid
3,4,5,6-tetrabromo-ortho-cresol 1% + zinc undecenoate 5% + undecenoic acid 1% + zinc oxide 5% dusting powder Unknown Cell Type 2
3,4,5,6-tetrabromo-ortho-cresol 1% + zinc undecenoate 5% + undecenoic acid 1% + zinc oxide 5% dusting powder, 375 g Unknown Cell Type 2
3,4,5,6-tetrabromo-ortho-cresol 1% + zinc undecenoate 5% + undecenoic acid 1% + zinc oxide 5% dusting powder, 50 g Unknown Cell Type 2
3,4,5,6-tetrabromo-ortho-cresol 10 mg / 1 g + undecenoic acid 10 mg / 1 g + zinc oxide 50 mg / 1 g + zinc undecenoate 50 mg / 1 g dusting powder (medicinal product unit of use) Unknown Cell Type 2
3,4,5,6-tetrabromo-ortho-cresol 10 mg / 1 g + undecenoic acid 10 mg / 1 g + zinc oxide 50 mg / 1 g + zinc undecenoate 50 mg / 1 g dusting powder, 375 g (medicinal product pack) Unknown Cell Type 2
3,4,5,6-tetrabromo-ortho-cresol 10 mg / 1 g + undecenoic acid 10 mg / 1 g + zinc oxide 50 mg / 1 g + zinc undecenoate 50 mg / 1 g dusting powder, 50 g (medicinal product pack) Unknown Cell Type 2
3TC (lamivudine 10 mg / 1 mL) oral liquid solution, 1 mL measure (trade product unit of use) Unknown Cell Type 2
3TC (lamivudine 10 mg / 1 mL) oral liquid solution, 240 mL (trade product pack) Unknown Cell Type 2
3TC (lamivudine 10 mg / 1 mL) oral liquid solution, 240 mL, bottle (containered trade product pack) Unknown Cell Type 2
3TC (lamivudine 150 mg) film-coated tablet (trade product unit of use) Unknown Cell Type 2
3TC (lamivudine 150 mg) film-coated tablet, 60 tablets (trade product pack) Unknown Cell Type 2
3TC (lamivudine 150 mg) film-coated tablet, 60 tablets, bottle (containered trade product pack) Unknown Cell Type 2
3TC (lamivudine 300 mg) film-coated tablet (trade product unit of use) Unknown Cell Type 2
3TC (lamivudine 300 mg) film-coated tablet, 30 tablets (trade product pack) Unknown Cell Type 2
3TC (lamivudine 300 mg) film-coated tablet, 30 tablets, bottle (containered trade product pack) Unknown Cell Type 2
3TC 10 mg/mL oral liquid solution Unknown Cell Type 2
3TC 10 mg/mL oral liquid solution, 240 mL Unknown Cell Type 2
3TC 10 mg/mL oral liquid solution, 240 mL, bottle Unknown Cell Type 2
3TC 150 mg film-coated tablet Unknown Cell Type 2
3TC 150 mg film-coated tablet, 60 Unknown Cell Type 2
3TC 150 mg film-coated tablet, 60, bottle Unknown Cell Type 2
3TC 300 mg film-coated tablet Unknown Cell Type 2
3TC 300 mg film-coated tablet, 30 Unknown Cell Type 2
3TC 300 mg film-coated tablet, 30, bottle Unknown Cell Type 2
46, XX true hermaphrodite 46,XX ovotesticular disorder of sex development
5% Acetic acid Acetic acid
6-Iodomethylnorcholesterol[131I] 8-30MBq/mL injection Norcholestenol iodomethyl (131-I) only product in parenteral dose form
6-Iodomethylnorcholesterol[131I] 8-30MBq/mL powder for injection solution vial Norcholestenol iodomethyl (131-I) only product in parenteral dose form
6-Iodomethylnorcholesterol[131I]37MBq/mL injection Norcholestenol iodomethyl (131-I) only product in parenteral dose form
6-ketoprostaglandin F1 6-ketoprostaglandin F1 alpha
6-minute walk test 6 minute walk test distance
influenza virus quadrivalent vaccine 2015 injection, syringe influenza quadrivalent adult vaccine 2015 injection, 0.5 mL syringe
influenza virus quadrivalent vaccine 2015 injection, 10 x 0.5 mL syringes influenza quadrivalent adult vaccine 2015 injection, 10 x 0.5 mL syringes
A/Michigan/45/2015 (H1N1)pdm09-like virus 60 microgram + A/Singapore/INFIMH-16-0019/2016 (H3N2)-like virus 60 microgram + B/Phuket/3073/2013-like virus 60 microgram injection, 0.5 mL syringe (medicinal product unit of use) influenza trivalent geriatric vaccine 2018 injection, 0.5 mL syringe
influenza trivalent geriatric vaccine 2018 injection, 10 x 0.5 mL syringes influenza trivalent geriatric vaccine 2018 injection, 10 x 0.5 mL syringes
influenza trivalent geriatric vaccine 2018 injection, 5 x 0.5 mL syringes influenza trivalent geriatric vaccine 2018 injection, 5 x 0.5 mL syringes
ABO blood group antibody system ABO blood group system
ADT Booster (diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 0.5 mL syringe (trade product unit of use) Unknown Cell Type 2
ADT Booster (diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 0.5 mL vial (trade product unit of use) Unknown Cell Type 2
ADT Booster (diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL syringe (containered trade product pack) Unknown Cell Type 2
ADT Booster (diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL syringe (trade product pack) Unknown Cell Type 2
ADT Booster (diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL vial (containered trade product pack) Unknown Cell Type 2
ADT Booster (diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL vial (trade product pack) Unknown Cell Type 2
ADT Booster (diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 5 x 0.5 mL syringes (containered trade product pack) Unknown Cell Type 2
ADT Booster (diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 5 x 0.5 mL syringes (trade product pack) Unknown Cell Type 2
ADT Booster (diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 5 x 0.5 mL vials (containered trade product pack) Unknown Cell Type 2
ADT Booster (diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 5 x 0.5 mL vials (trade product pack) Unknown Cell Type 2
ADT Booster injection: suspension, 0.5 mL syringe ADT Booster injection, 0.5 mL syringe
ADT Booster injection: suspension, 0.5 mL syringe ADT Booster injection, 0.5 mL syringe
ADT Booster injection: suspension, 0.5 mL syringe ADT Booster injection, 0.5 mL syringe
ADT Booster injection: suspension, 5 x 0.5 mL syringes ADT Booster injection, 5 x 0.5 mL syringes
ADT Booster injection: suspension, 5 x 0.5 mL syringes ADT Booster injection, 5 x 0.5 mL syringes
ADT Booster (diphtheria toxoid vaccine 2 international units / 0.5 mL + tetanus toxoid vaccine 20 international units / 0.5 mL) injection suspension, 0.5 mL syringe (trade product unit of use) ADT Booster injection, 0.5 mL syringe
ADT Booster injection suspension, 0.5 mL syringe ADT Booster injection, 0.5 mL syringe
ADT Booster injection suspension, 0.5 mL syringe ADT Booster injection, 0.5 mL syringe
ADT Booster (diphtheria toxoid vaccine 2 international units / 0.5 mL + tetanus toxoid vaccine 20 international units / 0.5 mL) injection suspension, 5 x 0.5 mL syringes (containered trade product pack) ADT Booster injection, 5 x 0.5 mL syringes
ADT Booster injection suspension, 5 x 0.5 mL syringes ADT Booster injection, 5 x 0.5 mL syringes
ADT Booster injection suspension, 0.5 mL syringe Unknown Cell Type 2
ADT Booster injection suspension, 0.5 mL syringe Unknown Cell Type 2
ADT Booster injection suspension, 0.5 mL syringe Unknown Cell Type 2
ADT Booster injection suspension, 0.5 mL vial Unknown Cell Type 2
ADT Booster injection suspension, 0.5 mL vial Unknown Cell Type 2
ADT Booster injection suspension, 0.5 mL vial Unknown Cell Type 2
ADT Booster injection suspension, 5 x 0.5 mL syringes Unknown Cell Type 2
ADT Booster injection suspension, 5 x 0.5 mL syringes Unknown Cell Type 2
ADT Booster injection suspension, 5 x 0.5 mL vials Unknown Cell Type 2

Page 1 of 1313 Next End

Reference Sets

Australian dialect reference set

Unit of use quantity reference set

Reference set descriptor

Back to Start